Free shipping on all orders over $ 500

PHT-427

Cat. No. M1900

All AbMole products are for research use only, cannot be used for human consumption.

PHT-427 Structure
Size Price Availability Quantity
10mg USD 50  USD50 In stock
25mg USD 110  USD110 In stock
50mg USD 180  USD180 In stock
100mg USD 305  USD305 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PHT-427 is a novel small-molecule inhibitor of PDPK1/Akt signaling with significant antitumor activity and minimal toxicity in vivo. The phosphatidylinositol 3-kinase/AKT signaling pathway plays a critical role in activating survival and antiapoptotic pathways within cancer cells. PHT-427 binds selectively to the PH domain of AKT, causing apoptosis at low micromolar concentrations. And it also binds to the PH domain of PDPK1. PHT-427 inhibited Akt and PDPK1 signaling and their downstream targets in sensitive but not resistant cells and tumor xenografts. PHT-427 induces apoptosis (IC50 = 6.3 μM), mainly on Akt Ser473 residue and less strongly on the Akt Thr308 residue without affecting total Akt protein expression. PHT-427 also shows antiproliferation in Panc-1 cells (IC50 = 65 μM).

Protocol (for reference only)
Cell Experiment
Cell lines Human MiaPaCa-2, BxPC-3, and Panc-1 pancreatic cancer cells
Preparation method Cell cytotoxicity assay
Cell growth inhibition was determined using a micro-cytoxicity assay. Cells were plated in 96-well micro-cytoxicity at 5,000–10,000 cells per well (depending on cell doubling time) and grown for 7 days. Compounds dissolved in DMSO were added directly to the media, at various concentrations ranging from 1 to 50 μM. The endpoint was spectrophotometric determination of the protein content of each well using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. A concentration-response relationship at two or more concentration levels was used to obtain an IC50 for the compound.
Concentrations 1~50 μM
Incubation time 48 h
Animal Experiment
Animal models BxPC-3, Panc-1, MiaPaCa-2, PC-3, SKOV-3, A-549 or MCF-7 cells tumour model in female scid mice
Formulation 40 to 50 mg/ml in sesame seed oil
Dosages 200 mg/kg twice daily for 10 days
Administration oral
Chemical Information
Molecular Weight 409.61
Formula C20H31N3O2S2
CAS Number 1191951-57-1
Solubility (25°C) DMSO 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Meuillet EJ, et al. Mol Cancer Ther. Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.

[2] Moses SA, et al. Cancer Res. In vitro and in vivo activity of novel small-molecule inhibitors targeting the pleckstrin homology domain of protein kinase B/AKT.

Related Akt Products
(E)-Akt inhibitor-IV

(E)-Akt inhibitor-IV is a PI3K-Akt inhibitor, with potent cytotoxic.

K-80003

K-80003 is a potent inhibitor of tRXRα-dependent Akt activation and cancer cell growth.

FPA-124 

FPA-124, a cell-permeable copper complex, is a selective Akt inhibitor with an IC50 of 0.1 μM.

SPOP-IN-1 

SPOP-IN-1 is a selective SPOP E3 ubiquitin ligase inhibitor.

10-DEBC hydrochloride 

10-DEBC hydrochloride is a selective Akt inhibitor, with an IC50 of 1.28 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: PHT-427 supplier, Akt, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.